The results are shown in Fig. 7 and were found to be mainly enriched in tumor-related and immune-related pathways: pancreatic cancer, pathways in cancer, primary immunodeficiency, rig i-like receptor (RLR) signaling pathway, t cell receptor signaling pathway, and Wnt signaling pathway. This evidence concerns the gene DHX58 and familial pancreatic carcinoma.